rabeprazole has been researched along with fluvoxamine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Shimizu, M; Sugawara, K; Tateishi, T; Uno, T; Yasui-Furukori, N | 1 |
Niioka, T; Shimizu, M; Sugawara, K; Tateishi, T; Uno, T; Yasui-Furukori, N | 1 |
Niioka, T | 1 |
1 review(s) available for rabeprazole and fluvoxamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for rabeprazole and fluvoxamine
Article | Year |
---|---|
Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cross-Over Studies; Cytochrome P-450 CYP2C19; Double-Blind Method; Enzyme Inhibitors; Female; Fluvoxamine; Heterozygote; Homozygote; Humans; Male; Mixed Function Oxygenases; Omeprazole; Rabeprazole; Selective Serotonin Reuptake Inhibitors | 2006 |
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Algorithms; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Enzyme Inhibitors; Female; Fluvoxamine; Half-Life; Heterozygote; Homozygote; Humans; Male; Mixed Function Oxygenases; Rabeprazole; Regression Analysis; Sulfides; Time Factors | 2006 |
1 other study(ies) available for rabeprazole and fluvoxamine
Article | Year |
---|---|
Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Specimen Collection; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Monitoring; Fluvoxamine; Genotype; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole | 2011 |